Wedmont Private Capital Boosts Holdings in Kenvue Inc. $KVUE

Wedmont Private Capital boosted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 720.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 83,827 shares of the company’s stock after buying an additional 73,610 shares during the quarter. Wedmont Private Capital’s holdings in Kenvue were worth $1,403,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Salomon & Ludwin LLC purchased a new position in shares of Kenvue during the 3rd quarter worth approximately $25,000. NBT Bank N A NY grew its holdings in Kenvue by 180.3% during the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after buying an additional 1,006 shares during the last quarter. Cornerstone Planning Group LLC increased its position in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after buying an additional 1,361 shares in the last quarter. Golden State Wealth Management LLC increased its position in Kenvue by 150.1% during the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after buying an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont raised its holdings in shares of Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after acquiring an additional 804 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Citigroup increased their price objective on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. UBS Group boosted their target price on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and reduced their target price for the company from $23.00 to $18.00 in a report on Friday, January 30th. Barclays lifted their price target on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Friday, March 6th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. Three equities research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $19.58.

Kenvue Stock Performance

NYSE KVUE opened at $17.43 on Monday. The business’s 50-day moving average price is $17.97 and its 200 day moving average price is $17.17. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17. The company has a market capitalization of $33.40 billion, a PE ratio of 22.63, a price-to-earnings-growth ratio of 3.95 and a beta of 0.51. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The company had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. During the same quarter in the previous year, the business earned $0.26 EPS. The firm’s revenue was up 3.2% on a year-over-year basis. On average, research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were issued a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date was Wednesday, February 11th. Kenvue’s payout ratio is presently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.